SCHEMBL7013169

SCHEMBL7013169

COc1ccc(Cl)c(Oc2c(C)nc(-c3ncccn3)nc2O)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.42
▸ CYP19A1 P11511 3/20 0.39
▸ RAB9A P51151 4/20 0.37
▸ LMNA P02545 3/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ POLB P06746 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ CLK4 Q9HAZ1 4/20 0.36
▸ CYP3A4 P08684 3/20 0.36
▸ CYP1A2 P05177 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ GLA P06280 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ DYRK1A Q13627 1/20 0.36
▸ SCN9A Q15858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7010336 0.88 DHPS (0.41) IDH1RAB9ALMNAALDH1A1TSHR
SCHEMBL7013160 0.81 EDNRB (0.41) LMNAALDH1A1SMN1; SMN2TSHRMEN1
SCHEMBL4427054 0.76 EDNRB (0.43) LMNAALDH1A1SMN1; SMN2TSHRMEN1
SCHEMBL7011888 0.73 EDNRA (0.57) EDNRBEDNRA
SCHEMBL8328712 0.73 KMT2A (0.37) RAB9ALMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL7009624 0.72 EDNRB (0.41) RAB9ALMNAALDH1A1SMN1; SMN2TSHR
SCHEMBL7586198 0.71 KDM4E (0.47) LMNAMEN1KMT2AEDNRBEDNRA
SCHEMBL1257596 0.70 DHPS (0.52) EDNRBEDNRA
SCHEMBL1937757 0.70 EDNRA (0.49) CYP19A1EDNRBEDNRA
SCHEMBL7298739 0.70 CDK1 (0.43) RAB9ALMNAALDH1A1SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0601386-B1 Sulphonamides HOFFMANN LA ROCHE (CH) 2003-02-05 — — EP disclosed
US-5420129-A Treatment of hypertension, ischemia, vasospasms, angina HOFFMANN-LA ROCHE INC. (US) 1995-05-30 — — US disclosed
EP-0601386-A1 Sulphonamides F. HOFFMANN-LA ROCHE AG (CH) 1994-06-15 — — EP disclosed
Send feedback